The Dulco® range offers effective options to help relieve constipation based on your needs: from overnight relief in 6-12 hours (Dulcolax® Adult gasto-resistant tablets and Dulcolax® Adult pico liquid) or relief in 10-30 minutes (Dulcolax® Twelve Plus suppositories) as well as stool softening product for gentle relief (DulcoEase® capsules). Dulcolax® Adult gastro-resistant tablets and Dulcolax® Tw
elve plus suppositories contain bisacodyl. DulcoEase® capsules contain docusate sodium. Always read the label. More info: www.dulcolax.co.uk
Products
Our range includes stimulant laxatives for overnight relief or relief in 10-30 minutes as well as stool softening osmotic product for gentle and effective relief.
• For gentle relief: DulcoEase® capsules work to soften and get things moving comfortably again.
• For overnight relief in 6-12 hours: Dulcolax® Adult tablets work by stimulating bowel movements to provide predictable overnight relief in 6-12 hours. If you prefer liquid format, there’s also Dulcolax® Adult pico liquid.
• For fast relief: Dulcolax® Twelve plus suppositories work by stimulating the bowel movements to provide relief in minutes, helping you feel in control again. Dulcolax® Adult gastro- resistant tablets and Dulcolax® Twelve plus suppositories contain bisacodyl. More info: www.dulcolax.co.uk
About Sanofi
Sanofi is a global healthcare leading company. With more than 100,000 people across 100 countries, and over 1200 in the UK, we transform scientific innovation into healthcare solutions to support support people across the country, and the globe. Our mission to empower lives and improve access to healthcare guides our actions every day. More info: www.sanofi.co.uk
Safety Information and Adverse Events reporting
If you have a question or request about a Sanofi product, please contact us via the "contact us" form located at https://www.sanofi.co.uk/en/about-us/sanofi-in-the-uk/contact-us or email us at uk-medicalinformation@sanofi.com or call us on +(44) 0800 035 2525. If you need to report an adverse event about a Sanofi product, please email us at CHC.PVUK@sanofi.com or call us at 0800 0902314 (Monday - Friday). Information on adverse event reporting to the UK Health Authority can be found at www.mhra. gov.uk/yellowcard/
Please note, we cannot provide medical advice on your symptoms, if you are concerned about your symptoms, or they worsen, you should contact your doctor or healthcare provider. Sanofi (and its group of companies) continually monitor the safety of its products, therefore, if you mention any safety-related information that you or someone else has experienced (or is experiencing) with a Sanofi product, Sanofi may contact you for further details and are obliged to process this information for the sole purpose of evaluating the safety of Sanofi products. This is likely to involve the reporting of such information to national and international health authorities and regulatory bodies, albeit in de-identified form (wherever practicable). Sanofi will handle all Personal Information received in confidence and in accordance with applicable laws. Terms of Use
Please see Sanofi's terms of use at the link below https://www.sanofi.co.uk/en/other-legal-notices/social-media-terms-conditions
This page is for general information only. When using on this page. please comply with Facebook's terms of use and posting guidelines in addition to the below. Deleting messages and blocking users. This page is not intended as a forum to discuss technical queries regarding specific pharmaceutical products, medical conditions or as a substitute for professional medical advice. Sanofi reserves the right to remove any postings at its sole discretion. You may only use this page for lawful purposes. The following actions may result in the immediate deletion of posted messages or, in the case of gross or repeated violations, the exclusion of any further messages from a user and the blocking of his or her account from viewing this page:
• Personal insults or degrading comments of any kind;
• Disparaging, discriminatory or harassing comments;
• Any violation of the rights of third parties, including copyright or other intellectual property rights;
• Reference prescription only medicines;
• Disclose personal information about a person or their health status;
• Comments that do not relate to the messages under discussion or are off-topic;
• Calls to promote or incite violence, hateful conduct, political or any illegal activity;
• Offering goods or services or using this page as an advertising space;
advertising space;
• Sharing any material that contains viruses, Trojan horses, worms, time-bombs, keystroke loggers, spyware, adware or any other harmful programs;
• Spam, i.e. any form of automatically generated content or repeatedly posting the same comment
Privacy Notice
Facebook uses cookies to collect personal data about visitors to this page and certain anonymous statistical data will be available to Sanofi (operating in the UK as Opella Healthcare UK Limited) via the Facebook Insights Tool. For the purposes of data protection laws, Sanofi and Facebook are data Controllers. The data received by Sanofi includes the average age, location of device, gender and interests (like, follow, share etc.) of all users of this page. This information enables Sanofi to target a specific audience with relevant promotional content. The legal basis for Sanofi processes this data is that it is necessary for our legitimate interests to develop our products/services and grow our business. Snofi will process the personal data you provide in accordance with company policy and applicable data protection laws. For more information about Sanofi's data processing activities, including the details of who to contact if you have any questions or complaints, please see our privacy policy available at http://www.sanofi.co.uk/en/privacy-policy. For more information about how Facebook processes your personal data please visit http://www.facebook. com/full_data_use_policy. Copyright
Sanofi is the owner or the licensee of all intellectual property rights in this page. All works on this page are protected by copyrights laws and treaties around the world. All such rights are reserved. You may print off or download any content off this page for personal use but you must not modify any materials you have printed off or downloaded in any way. You are not permitted to use any part of the content of this page for commercial purposes without obtaining a license to do so from Sanofi or our licensors. Disclaimer
This page may include information and materials uploaded by others. This information has not been verified or approved by Sanofi. The views expressed by others on this page do not represent the views or opnions of Sanofi. This page may contain links to other sites belonging to third parties. Clicking on such a link will direct you away from the Dulcolax® UK page. Such links should not be interpreted as approved or endorsed by Sanofi. We have no control over the contents of sites belonging to third parties. Although we make reasonable efforts to update the information on this page, Sanofi makes no representations, warranties or guarantees of any kind about the accuracy or completeness of the content. In no event shall Sanofi be liable to you or anyone else for any decision made or action taken by you in reliance on information on this page. MAT-GB-2101790 (v3.0) January 2022
